Ratings for Inspire Medical Systems (NYSE:INSP) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Inspire Medical Systems, presenting an average target of $215.7, a high estimate of $260.00, and a low estimate of $159.00. A decline of 27.06% from the prior average price target is evident in the current average.

Understanding Analyst Ratings: A Comprehensive Breakdown

The standing of Inspire Medical Systems among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

To gain a panoramic view of Inspire Medical Systems's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.

Stay up to date on Inspire Medical Systems analyst ratings.

Get to Know Inspire Medical Systems Better

Inspire Medical Systems's Economic Impact: An Analysis

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Inspire Medical Systems displayed positive results in 3 months. As of 30 September, 2023, the company achieved a solid revenue growth rate of approximately 40.4%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -5.57%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): Inspire Medical Systems's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -1.59%, the company may face hurdles in achieving optimal financial returns.

Return on Assets (ROA): Inspire Medical Systems's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.36%, the company may face hurdles in achieving optimal financial performance.

Debt Management: Inspire Medical Systems's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.05.

Understanding the Relevance of Analyst Ratings

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.

This article was generated by Benzinga's automated content engine and reviewed by an editor.